4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-24-018174
Chief Executive Officer sold 6,370 shares at $79.67 ($507,498)
- Chief Executive Officer acquired 13,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kulkarni Samarth Chief Executive Officer | 2024-02-18 | Option exercise | +13,250 | 200,627 | D | ||
| Kulkarni Samarth Chief Executive Officer | 2024-02-20 | Sale | −6,370 | $79.67 | $507,498 | 194,257 | D |
| Derivatives | |||||||
| Kulkarni Samarth Chief Executive Officer | 2024-02-18 | Option exercise · Restricted Stock Units | −13,250 | 26,500 | D | ||
| Open-market sales · 6,370 sh · avg $79.67 · $507,498 | |||||||
Loading xslF345X05/ownership.xml…